Where does Gilead Pharmasset LLC rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Gilead Pharmasset LLC ranks #6,333 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Gilead Pharmasset LLC hold?

Gilead Pharmasset LLC holds 53 US utility patents granted between 2015 and 2021, spanning 11 technology areas.

What is Gilead Pharmasset LLC's Innovation Score?

Gilead Pharmasset LLC has an Innovation Score of 32.4 out of 100 (41st percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Gilead Pharmasset LLC focus on?

Gilead Pharmasset LLC's top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 52 patents, ranking #338 of 6,058 assignees active in that subclass. Grants appear in 11 CPC subclasses total.

Is Gilead Pharmasset LLC's patent grant rate increasing or decreasing?

Gilead Pharmasset LLC's recent grant velocity is -80% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Gilead Pharmasset LLC's patents?

Gilead Pharmasset LLC's patents average 11.5 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Gilead Pharmasset LLC patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Gilead Pharmasset LLC

USPTO PatentsView assignee record - 53 granted patents across 11 technology areas, recorded in grant years 2015–2021. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Gilead ranks #6,333 of 49,997 tracked US assignees by granted-patent volume, with 53 patents across 11 technology areas.

#6,333
of 49,997 US assignees by volume: 41st percentile
by Innovation Score (32.4/100): 11.5
avg claims per patent: -80%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R6333 · US Corporation #6,333 · 53 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-PAR · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-SMALL 53 grants
UPPER-Q #6,333/49,997
PHOTO-FINISH Flamel Ireland
CPC-FOCUS A61P · 11 areas
INNOV-THIN 32.4/100
CLAIMS-PAR 11.5 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -80% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Flamel Ireland Limited (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Gilead’s 32.4 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 13.8 pts (43%) Velocity 0.0 pts (0%) Breadth 11.7 pts (36%) Claim depth 6.9 pts (21%)

Qualcomm Incorporated · highest

85
Allnex IP r L · near

32
DAJ Global Partners · near

32
Gilead Pharmasset · this assignee

32
Motivo · near

32
NEC Lighting · near

32
3D Lighting… · lowest

7

What this shows Gilead's Innovation Score is 32.4/100 (41st percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Gilead?

Each dot is one of Gilead’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Gilead’s own 11.5 claims/patent is at or below the 14.2 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Gilead vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Gilead's grants concentrate

Gilead Pharmasset LLC is a focused PatentsView assignee: 11 CPC subclasses with 98.1% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2017 (13 grants) versus a trough of 4 in 2021. By volume, Gilead sits between Foshan Shunde Midea Electrical Heating Appliances Manufacturing Co., Ltd. and Hello Inc..

Foshan Shunde Mid…

53
Fuzhou University

53
Flamel Ireland

53
Greenlee Tools

53
Gree Green Refrig…

53
Guangzhou Shiyuan…

53
Harsco

53
Hello

53
Gilead Pharmasset ◀

53

What this shows Gilead holds 53 patents at rank #6,333, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Gilead

By rank, the assignees closest to #6,333 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Gilead's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Gilead, neither rank-band nor same-CPC leaders (those blocks stay above). In A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…), Gilead ranks #338 of 6,058 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (32 here).

NEC Lighting, Ltd. 32 Allnex IP S.a.r.L. 32 Motivo, Inc. 32 DAJ Global Partners LLC 32

Similar claim depth

Nearest assignees by average claims per patent (11.5 here).

SK Global Chemical Co., Ltd. 11.5 avg Kagoshima University 11.5 avg Shaanxi Lighte Optoelectronics Material Co., Ltd. 11.5 avg New Shicoh Motor Co., Ltd. 11.5 avg

Gilead's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

32 41st percentile higher than 41% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2021

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Gilead Pharmasset LLC patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	12	22.6%
2016	7	13.2%
2017	13	24.5%
2018	7	13.2%
2019	5	9.4%
2020	5	9.4%
2021	4	7.5%

Which technologies does Gilead Pharmasset LLC patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 52

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 40

C07D - Heterocyclic Compounds 34

C07H - SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids 16

C07F - Acyclic, Carbocyclic OR Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium OR Tellurium 12

Y02A - Technologies FOR Adaptation TO Climate Change 9

C07B - General Methods OF Organic CHEMISTRY; Apparatus Therefor 8

Y02P - Climate Change Mitigation Technologies IN THE Production OR Processing OF Goods 7

C07C - Acyclic OR Carbocyclic Compounds 3

C07K - Peptides 2

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 1

Top 11 of 11 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Gilead Pharmasset LLC's patent record in context - here's where to go next.

Gilead Pharmasset LLC's lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 98.1% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #6,333 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Gilead Pharmasset LLC against Foshan Shunde Midea Electrical Heating Appliances Manufacturing Co., Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 32.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.